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Abstract
To date, the role of transcription factors (TFs) in the progression of disease for many pathogens is yet to be studied in detail.
This is probably due to transient, and generally low expression levels of TFs, which are the central components controlling
the expression of many genes during the course of infection. However, a small change in the expression or specificity of a TF
can radically alter gene expression. In this study, we combined a number of quality-based selection strategies including
structural prediction of modulated genes, gene ontology and network analysis, to predict the regulatory mechanisms
underlying pathogenesis of Streptococcus pneumoniae (the pneumococcus). We have identified two TFs (SP_0676 and
SP_0927 [SmrC]) that might control tissue-specific gene expression during pneumococcal translocation from the
nasopharynx to lungs, to blood and then to brain of mice. Targeted mutagenesis and mouse models of infection confirmed
the role of SP_0927 in pathogenesis and virulence, and suggests that SP_0676 might be essential to pneumococcal viability.
These findings provide fundamental new insights into virulence gene expression and regulation during pathogenesis.
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Introduction
Bacterial pathogens use different strategies and elicit a variety of
virulence factors during infection of the host to establish disease.
For instance, enteric pathogens such as Escherichia coli, Salmonella,
Shigella and Vibrio cholerae employ a number of secretion systems and
effector molecules to subvert their target host cells [1,2]. In
addition, during infection, pathogenic bacteria activate a number
of transcription factors (TFs) which control the regulatory cascades
that govern their physiological adaptation, pathogenesis and
virulence [3–5]. For example, in V. cholerae, studies have shown
that regulation of virulence gene expression is governed by ToxR
and ToxT [2,6–8]. However, the TFs, regulatory mechanisms,
molecular networks and precise events that control the transloca-
tion of other important pathogenic bacteria such as Streptococcus
pneumoniae (the pneumococcus) from the initial site of infection into
deeper host tissues, are yet to be fully elucidated [9,10].
Nevertheless, the pneumococcus continues to be responsible for
high global morbidity and mortality resulting from pneumonia,
bacteremia, meningitis and otitis media [11], largely due to our
incomplete understanding of the biology of pneumococcal disease
[12].
To address these deficiencies, we initially carried out systematic
microarray comparisons of gene expression kinetics of two
pneumococcal strains in the nasopharynx, lungs, blood and brain
of mice. These analyses yielded a number of niche-specific, up-
regulated genes that contribute to pathogenesis, some of which
were shown to encode good vaccine candidates [13,14]. Surpris-
ingly, our investigations and similar in vivo transcriptomic analyses
by others [13–15] did not identify any significantly up-regulated
TFs, despite their prominent role in bacterial pathogenesis [3]. We
reasoned that this is probably due to low, and generally transient,
expression of TFs, although a small change in the expression or
specificity of a TF can radically alter gene expression. Therefore,
in this study, we utilized our existing transcriptomic data to
comprehensively analyze TFs controlling the progression of
pneumococci from the nasopharynx to deeper host tissues by
comparing the ratio of expression of these genes between distinct
host niches during pathogenesis.
Materials and Methods
Ethics Statement
Outbred 5- to 6-week-old female CD1 (Swiss) mice were used in
all experiments. The Animal Ethics Committee of The University
of Adelaide approved all animal experiments (Project Number: S-
2010–001). The study was conducted in compliance with the
Australian Code of Practice for the Care and Use of Animals for
Scientific Purposes (7th Edition 2004) and the South Australian
Animal Welfare Act 1985.
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Bacterial strains and growth conditions
The pneumococcal strains used in this study were clinical blood
isolates WCH43 (serotype 4; Sequence Type 205) and WCH16
(serotype 6A; Sequence Type 4966). Previous mouse intranasal
challenge experiments in our laboratory with both strains
indicated that WCH43 is more virulent than WCH16. Neverthe-
Figure 1. Expression and of SP_0676 and SP_0927 in S. pneumoniae WCH16 (A) and WCH43 (B), showing up-regulation and high
correlation of both TFs in all niches except the blood.
doi:10.1371/journal.pone.0070862.g001
Figure 2. Bioinformatic prediction model for two TFs that potentially contribute to pathogenesis and virulence of S. pneumoniae.
Gene regulatory network analysis of SP_0676 and SP_0927 in the brain versus blood. The interaction network consists of ilv, pyr, fab and cia
subnetworks. Dashed arrows represent positive or negative regulation; dashed arrows with a › sign represents positive regulation.
doi:10.1371/journal.pone.0070862.g002
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less, both strains have a propensity to translocate to the brain of
infected mice. Furthermore, WCH43 infection of mice demon-
strates the ‘‘classical’’ disease progression from the nasopharynx to
the lungs and dissemination to blood and then to the brain
[16,17]. However, WCH16 seems to progress directly to the brain
with minimal lung and blood involvement, suggesting that the
preferred route for WCH16 pathogenesis is by direct translocation
into the brain via the nasopharyngeal epithelium. Serotype-
specific capsule production was confirmed by Quellung reaction,
as described previously [18]. Opaque-phase variants of the strains,
selected on Todd-Hewitt broth supplemented with 1% yeast
extract (THY)-catalase plates [19], were used in all animal
experiments. Before infection, the bacteria were grown statically
at 37uC in serum broth (SB) to A600 of 0.16 (equivalent to approx.
56107 CFU/ml).
Analysis of in vivo microarray data of pneumococcal
movement between different host tissues
For this analysis, we utilized microarray data of in vivo-derived
RNA samples obtained from our previous studies [13,14]. Two
color microarray analysis was carried out where the relative
expression of each gene in one niche was calculated in comparison
to expression in the previous niche when bacteria moves from
nasopharynxRlungsRbloodRbrain. The goal of this analysis was
to unravel pneumococcal gene expression kinetics in the
nasopharynx, lungs, blood and brain of mice. The following
formula was used to calculate the relative expression of bacterial
genes in each niche versus the previous niche: Log2 [(Rmean –
morphR)/(Gmean – morphG)], where Rmeam and Gmean were
mean of Red and Green intensities, respectively (foreground
intensities) and morphG and morphR were Green and Red
background intensities. FlexArray package (McGill University,
Canada) was used to analyze microarray data.
In the context of gene selection, in addition to taking into
account the amount of gene expression (quantity of expression,
selected based on the relative fold change $2, and P-value of one-
sample t-test #0.05), different strategies were employed to select
genes based on quality of selection. The quality based gene
selection strategies were: stability of gene expression, in silico
structural analysis of overexpressed genes at the protein level and
GO classification (using our recently developed comparative GO
web application [20].
In the stability of gene selection strategy, we searched for the
genes showing the relative stability of up-regulation between
different niches. In other words, one criterion in gene selection
considered the pneumococcal genes that were continuously up-
regulated during transition from one niche to another (or at least
Figure 3. Molecular functional categories of genes (A), down-regulated, and (B), up-regulated in DSP_0927 mutant. (C and D),
Comparison of the sub-categories of down-regulated (C) and up-regulated (D) genes due to SP_0927 mutation under ‘‘catalytic activity’’ molecular
function group.
doi:10.1371/journal.pone.0070862.g003
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maintained the same level of expression). Another quality-based
gene selection strategy was protein structural prediction of up-
regulated genes. This was carried out using CLC Main
Workbench package (CLC bio company, Finland), ExPASY
(http://expasy.org/), pfam (http://pfam.sanger.ac.uk), KEGG
(http://www.genome.jp/kegg/), and Conserved Domains and
Protein Classification database (http://www.ncbi.nlm.nih.gov/
Structure/cdd/cdd.shtml). Regarding the lack of comprehensive
study on TFs, particular attention was paid to finding up-regulated
genes with helix-turn-helix/helix-loop-helix DNA binding and
Zinc finger structures, since these structures are the common
universal protein structure of TFs in all organisms. For gene
network analysis, up-regulated genes during progression from the
nasopharynx to lungs, blood and brain were used as input for
making the networks. A database was built using Pathway Studio 9
software (Elsevier, USA), which contains different gene interaction
information obtained from correlation expression analysis and
literature mining.
Functional catalogue of pneumococcal pathogenesis
through classification of bacterial modulated genes into
Gene Ontology (GO) groups in different host tissues
A comprehensive view of bacterial functional genomics can be
obtained by categorizing up-regulated/down-regulated genes into
a limited number of annotated GO groups. GO classification has
been well developed for eukaryotes; however, it has not been
extensively applied in understanding functional genomics of
bacteria. Here, we assigned GO groups to up-regulated and
down-regulated pneumococcal genes in both WCH16 and
WCH43 using our recently developed comparative GO web
application [20]. Specific attention was paid to GO classes
involved in regulatory mechanisms such as sequence-specific
DNA binding transcription factors, DNA binding, and two-
component response regulator activity. We used this classification
for increasing the quality of gene selection. More importantly, GO
classification increased our knowledge about bacterial functional
genome arrangement and shift during infection of different host
tissues. GO categories were classified as: biological process, cellular
component, and molecular function.
Figure 4. Functional genomics catalogues of S. pneumoniae WCH16 and WCH43 pathogenesis in different host tissues. (A and B),
Lungs versus Nasopharynx; (C and D), Blood versus Lungs; (E and F), Brain versus Blood. (G–J): Bioluminescent imaging of WCH16- or WCH43- infected
mice at 72 h post-challenge, showing bacteria in the nasopharynx, lungs, blood and brain. G and H; ventral views, I and J; dorsal views of infected
mice.
doi:10.1371/journal.pone.0070862.g004
Figure 5. Interaction network data for connectivity of SP_0746 to SP_0800 and SP_0967 (highlighted in yellow).
doi:10.1371/journal.pone.0070862.g005
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The effect of SP_0927 mutation on whole transcriptomics
and functional organization of pneumococcal genome
We were surprised that while the ratio in bacterial counts of
DSP_0927 mutant in the blood versus lungs was not significantly
different from that of the wild-type (WCH43), the mutant showed
reduced virulence. Therefore, we investigated transcriptional
changes that could be responsible for this phenomenon by
microarray comparisons of RNA harvested from wild-type and
DSP_0927 grown in SB to A600 = 0.16. Microarray experiments
were performed on whole genome S. pneumoniae PCR arrays
obtained from the Bacterial Microarray Group at St George’s
Hospital Medical School, London (http://bugs.sgul.ac.uk/). The
array was designed using TIGR4 base strain annotation [21] and
extra target genes from strain R6 [22]. The array design is
available in BmG@Sbase (Accession No. A-BUGS-14; http://
bugs.sgul.ac.uk/A-BUGS-14) and also ArrayExpress (Accession
No. A-BUGS-14). Microarray probes were generated using the
3DNA Array 900 MPX labeling kit (Genisphere) following the
manufacturer’s guidelines. The fluorescently labeled cDNAs for
the pair-wise comparison were then combined and hybridized to
the surface of the microarray, essentially as described previously
[23]. Microarray analysis was performed on a total of 3
independent hybridizations from three separate assays (including
Figure 6. Characterisation of mutants of S. pneumoniaeWCH43. (A), In vitro growth curves of mutants and wild-type. Data are mean6 SEM of
7 replicates for each time point for each strain. (B and C), Comparison of pathogenesis progress of mutants relative to wild-type; (B), DSP_0746; (C),
DSP_0927. Data are mean6 SEM of pathogenesis ratios for 16–24 mice for the mutants, and 40 mice for wild-type. Data were analyzed by unpaired t-
test, one tailed (**, P,0.01; ***, P,0.001). (D). Survival times for mice after intranasal (16107 CFU) challenge with mutants and wild-type. Each datum
point represents one mouse. Broken lines denote median survival time for each strain. Mice that survived beyond 14 days are indicated at the top of
the figure as .336. ** P,0.01; Mann-Whitney U-test, one-tailed. NS = Not significant.
doi:10.1371/journal.pone.0070862.g006
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one dye reversal), essentially as described previously [13,14,23,24].
The top 50 differentially expressed genes with p,0.05; (one
sample t-test) using log2 (647/546) ratios from each hybridization
were then subjected to functional catalogue classification using our
new web application [20] to unravel the impact of mutating
SP_0927 on pneumococcal functional genomics.
Relative Quantitation real-time RT-PCR
For a subset of selected pneumococcal genes that were
significantly differentially expressed between the nasopharynx,
lungs, blood and brain (and in the in vitro comparison of WCH43
with its isogenic DSP_0927 mutant) by microarray analysis,
relative gene expression were validated using a one-step Super-
script III PlatinumH qRT-PCR kit (Invitrogen) in a Light-
CyclerH480 II (Roche) as described previously [13]. The relative
gene expression was analyzed using the 22DDCT method [25]. The
reference gene was 16S rRNA. The primer pairs used for gene
expression analysis are listed in Table S6. All data were obtained
from three biological replicates.
Construction of mutants and assessment of bacterial
growth in vitro
S. pneumoniae derivatives with marked mutations in genes of
interest were constructed in WCH43 (serotype 4). Mutants were
constructed by overlap extension PCR as described previously [26]
and validated by PCR and sequencing to be in-frame deletion
mutation replacements. All PCR procedures were performed with
the Phusion High Fidelity Kit (FINNZYMES). The primer pairs
used for construction and validation of the mutants are listed in
Table S6. In order to evaluate the growth rate of the mutants in
comparison to the wild-type, bacterial strains were grown in SB
and A600 monitored overnight on a Spectramax M2 spectropho-
tometer (Millenium Science). For in vitro competition experiments,
mutant and wild-type bacteria were grown to A600 in SB and then
mixed at an input ratio of 1:1 in SB. At 1.5 and 3 h post
incubation, an aliquot of each sample was serially diluted in SB
and plated on blood agar and blood agar with a selective antibiotic
to determine the ratio of mutant to wild-type bacteria. Each
competition experiment was repeated at least twice. Competitive
indices were calculated as the ratio (6 SEM) of mutant to wild-
type bacteria recovered at each time point adjusted by the input
ratio.
Pathogenesis and virulence assessment of mutants
For pathogenesis experiments, S. pneumoniae derivatives with
mutations in genes of interest and the isogenic wild-type strain
were grown separately in SB to A600 = 0.16 (approx. 5610
7 CFU/
ml). For pathogenesis experiments, 8–10 mice were anesthetized
by intraperitoneal injection of pentobarbital sodium (Nembutal;
Rhone-Merieux) at a dose of 66 mg per g of body weight and
separately challenged i.n. with 50 ml suspension containing
approx. 2.56106 CFU of either wild-type or the isogenic mutant
(DSP_0746 and DSP_0927). At 48 h post-challenge, mice from
each separate infection experiment were sacrificed, bacteria were
enumerated from the nasopharynx, lungs blood and brain, as
described previously [13,14] The experiment was carried out at
least twice for each strain. Ratios of bacteria counts between
niches were determined and verified to follow log-normal
distribution by the log-normality test. Differences in ratios between
wild-type and mutants were compared using unpaired two-sample
t-test (one-tailed). To assess the virulence potential of mutants,
groups of 12 anesthetized mice were challenged i.n. with either
mutant or wild-type bacteria, as described previously [13,27] Each
mouse received 50 ml of bacterial suspension containing approx-
imately 16107 CFU in SB. The challenge dose was confirmed
retrospectively by serial dilution and plating of the inocula on
blood agar. The survival of mice was monitored four times daily
for the first 5 days, twice daily for the next 5 days, and then daily
until 14 days after challenge. Differences in median survival times
for mice between groups were analyzed by the Mann-Whitney U-
test (one-tailed).
Data Access
The data reported in this paper are archived at the following
databases: BmG@Sbase (http://bugs.sgul.ac.uk/E-BUGS-130 and
http://bugs.sgul.ac.uk/E-BUGS-133, and also ArrayExpress (ac-
cession number E-BUGS-130, and E-BUGS-133.
Results and Discussion
In this investigation, we have subjected our existing transcrip-
tomic data to bioinformatics and gene network prediction to
identify other genes (particularly TFs) critical to invasive pneu-
mococcal disease that have previously been missed by existing
conventional gene identification strategies.
Bioinformatic prediction of two TFs that potentially
contribute to pathogenesis and virulence of S.
pneumoniae
To characterize the tissue-specific pneumococcal TFs and genes
under their regulation, we used a variety of statistical and
bioinformatic techniques including correlation of expression, gene
network reconstruction, microarray and qPCR analysis. Bioinfor-
matic gene selection criteria also included stability of gene
expression, in silico structural analysis of over-expressed genes for
DNA-binding motifs (such as helix-turn-helix (HTH) motifs, Zinc
finger motifs) and literature mining. In this manner, we found a
complex activated network of genes governing pneumococcal
virulence machinery commonly up-regulated during infection by
clinical pneumococcal strains WCH43 (serotype 4) and WCH16
(serotype 6A), particularly between lungs and the nasopharynx,
and between brain and blood. However, fewer genes were found
to be regulated during pneumococcal progression from the lungs
to blood (Table S1), in agreement with our previous observations
[14].
Protein structural prediction of up-regulated genes and gene
ontology (GO) classification using our recently developed
comparative GO web application [20] resulted in the identifica-
tion of two possible TFs influencing virulence, SP_0676 and
SP_0927. These two TFs belong to the LysR-type transcriptional
regulator family, which are highly conserved and ubiquitous
among bacteria [28]. Bioinformatic analyses revealed that
SP_0676 is a MtaR-type repressor, while SP_0927 (annotated as
SmrC by other workers [29–31] is a CmbR-type repressor (or
activator) in Streptococcaceae. Both possess HTH- DNA binding
motifs, they were up-regulated in all niches except the blood in
both strains, and their expression levels showed a high correlation
with each other [Pearson correlation test; P=0.001] (Figure 1).
The two TFs also exhibit 32.6% amino acid identity. Bioinfor-
matic prediction of the activated gene regulation network between
lungs and the nasopharynx, and between brain and blood allows
us to propose a model for a central role for these two TFs
(Figure 2). The activated network can be divided into sub-networks
such as ilv net (containing ilvABCDEN), pyr net (containing
pyrBDEF), fab net (fabDFHKZ), and cia net (ciaRH, and pepN)
(Figure 2; Table S1). We then conducted RT-PCR on S.
pneumoniae mRNA of pneumococci from the blood and brain, to
Transcription Factor in Pneumococcal Pathogenesis
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validate regulation of selected genes shown in our network
prediction, which yielded consistent results with the bioinformatic
prediction (not shown).
Other workers have characterized global regulation of gene
expression in S. pneumoniae by many TFs including CcpA [32],
CodY [33], Mga [34,35], PsaR [36,37], RitR [38], and two-
component systems [39] under in vitro conditions. However, to our
knowledge, niche-specific TF-modulation of virulence gene
expression during pneumococcal movement from the nose to
lungs, blood and brain directly attributable to these two TFs
(SP_0676 and SP_0927), is yet to be reported in the literature. We
then attempted to assess the contribution of both TFs to
pathogenesis and virulence by targeted deletion-replacement
mutagenesis. While a mutation in SP_0927 was achieved,
extensive efforts to construct a mutant of SP_0676 using various
pneumococcal transformation techniques and in different strains
were unsuccessful, suggesting that a mutation in this gene could be
lethal to the cell. This is in agreement with another recent study
indicating that SP_0676 is essential [10].
We then compared gene expression patterns of in vitro-grown
WCH43 with that of its isogenic DSP_0927 mutant by microarray
analysis. It was of interest that GO analysis of the differential gene
expression patterns using our recently developed comparative GO
web application [20] revealed that two-component sensor activity
and DNA binding functional groups were down-regulated in
SP_0927 mutant, while genes involved in carbon utilization and
transporter activity were up-regulated (Figure 3, A and B;
Table S2). The ‘‘catalytic activity’’ molecular function was
predominant in both the up- and down-regulated gene functional
categories. A sub-division of this category showed genes with
common, as well as unique enzymatic activities (Figure 3, C and
D).
Functional catalogues of pneumococcal pathogenesis in
different host tissues
As part of our investigation, we were interested in obtaining a
more comprehensive picture of the overall functional relationships
between the two identified TFs and other differentially regulated
genes in various niches during pathogenesis of disease at 48, 72
and 96 h post-infection. Our assessment was facilitated by the
comparative GO web application that we recently designed [20].
By analyzing the GO of up-regulated genes of WCH16 and
WCH43 in different tissues at various times after infection, we
found the highest increase of different functional groups in the
brain versus blood (Table S1). This included genes encoding
antioxidant enzymes (such as SP_0313, SP_0766 and SP_0784)
and a large number of brain-specific TFs such as MalR, DNA-
binding response regulator, arginine repressor, SP_0676 and
SP_0927 (Table S3). We found that the acetyl-CoA carboxylase
complex functional group (cellular component) predominated in
both brain and blood, suggesting a role for fatty acid biosynthesis
in pneumococcal pathogenesis. Interestingly, sequence-specific
DNA binding TF activity was an over-represented GO in both
lungs and brain (Figure 4, A–F), suggesting a key role for TFs in
pneumococcal functional genomics. Functional classification of
genes expressed by WCH16 and WCH43 during pathogenesis
differed mainly in blood: more GO groups were activated in
WCH43 (Figure 4, C and D), suggesting that these activated GO
groups may be important in maintaining fulminant bacteraemia
by this strain. We also found a major difference in gene expression
between both strains in blood; whereas only 3 genes were up-
regulated in the blood by WCH16 (relative to lungs), 16 genes
were up-regulated in the blood relative to lungs in WCH43
(Table S4). These marked differences in gene expression patterns
are consistent with the observed differences in the pathogenicity
characteristics of the two strains [13,16,17] and also correlates
with bioluminescence patterns of the two strains in mice (Figure 4,
G–J). Together, these analyses have increased our knowledge of
pneumococcal gene regulatory mechanisms and changes in gene
expression patterns during pathogenesis. Moreover, GO categories
of up-regulated genes of the two strains provide a comparative
view of different functional genomics organizations of pneumo-
coccal strains during pathogenesis (Figure 4, A–F).
Identification of up-regulated pneumococcal genes
critical to pathogenesis and virulence
Our search for genes that might be important to the disease
process revealed 4 genes, SP_2089, SP_0569, SP_0967 and
SP_0800, which showed high level of expression in both blood and
brain. Two of these 4 genes are part of a highly connected network
(Figure 5) suggesting that they could be good targets for blocking
pneumococcal virulence machinery from the nasopharynx to the
brain. Network analysis of these 4 genes revealed another gene,
SP_0746 (‘‘ClpP’’) that was highly connected with these genes,
suggesting that this gene might be involved (directly or indirectly)
in the modulation of expression of the 4 genes. This led us to select
it for further analysis.
We then evaluated the contribution of selected genes preferen-
tially up-regulated in various tissues to pathogenesis and virulence
by targeted mutagenesis. Deletion replacement mutation of these
genes (SP_0746, and SP_0927) did not adversely affect their
growth in serum broth, either separately or in competition with the
isogenic WCH43 wild-type strain (Figure 6A, Table S5). Consis-
tent with network analyses, ratio of pathogenesis data confirmed
that SP_0746 and SP_0927 contribute significantly to lung and
brain infection (Figure 6, B and C). In support of these findings,
intranasal challenge of mice showed that DSP_0746 and
DSP_0927 mutants were significantly attenuated for virulence
relative to wild-type (Figure 6D; p,0.01 in both cases). These data
are consistent with attenuation of SP_0746 (ClpP) in previous
findings, albeit in a different virulent (serotype 2 [D39]) genetic
background [40–42]. Other workers have also demonstrated
reduced virulence of a SP_0927 (‘‘SmrC’’) mutant generated by
signature-tagged mutagenesis in pneumonia and bacteremic
competition models in serotype 3 [29] and serotype 4 [30]
pneumococci. The delay in the onset of mortality provides a
window for host recovery and survival as well as adequate time for
effective antibiotic therapy, as was indeed the case in protection
and antibiotic treatment experiments with SP_0746 [43]. The
reduced virulence of the DSP_0927 mutant correlates with the
down-regulation of genes involved in virulence in WCH43, as
found in our microarray analysis (Figure 3A). These findings
reinforce the importance of TFs and the potential of network-
based gene prediction in control of infectious diseases.
Conclusion
Our comprehensive statistical and bioinformatic prediction of
pneumococcal TFs and genes under their regulation revealed for
the first time, a potential central gene network governing
pneumococcal pathogenesis and virulence machinery. We also
note that genes in the pyr net and cia net found in our predictive
network analysis were also contemporaneously identified using
Tn-seq, a high throughput screening strategy [10]. This not only
validates our strategy, but also represents a convergence of novel
strategies for a detailed understanding of bacterial pathogenesis.
We suggest that calculating the ratio of bacterial gene expression
in each host niche relative to the previous niche, in combination
with selection based on absolute gene expression level, might
Transcription Factor in Pneumococcal Pathogenesis
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provide an additional level of selection for genes critical to
pathogenesis. We also suggest that the use of quality-based metrics
such as GO classification, and network analysis in conjunction
with quantity-based gene selection criteria is likely to be more
robust for elucidating potential vaccine and therapeutic targets.
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